Skip to main content

US ClosedU.S. Closed

CNTX: Context Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Context Therapeutics Inc. , a biopharmaceutical company, develops products for the treatment of solid tumors.

52W Range

0thpctl

Volume

1.35×avg

Market Cap

35.25MUSD

P/E Ratio

-0.8TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Context Therapeutics Inc.

CNTXNASDAQ·USD·Closed

Context Therapeutics Inc.

CNTXNASDAQ·USD·Closed

$0.38

−7.79%

$0.38

−$0.03 (7.79%)

52W Range

0thpctl

Volume

1.35×avg

Mkt Cap

35.25MUSD

P/E

-0.8TTM

Div Yield

–ann